Join
Live feed
·
PRReleasevia Quantisnow
Armata Pharmaceuticals Inc. logo

Armata Pharmaceuticals Receives $3.7 Million in Additional Non-Dilutive Funding from U.S. Department of War to Support Advancement of AP-SA02 Phase 3 Development

ByQuantisnow·Wall Street's wire, on your screen.
ARMP· Armata Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ARMP (Armata Pharmaceuticals Inc.) and more on Quantisnow.